Gastrointestinal tract is one of the major systems affected by graft-versus-host disease (GVHD). Injury to the gut during conditioning therapy before stem-cell transplantation (SCT) plays a pivotal role in the initiation of inflammatory stimuli. We reviewed medical records of the patients who underwent SCT between April 2010 and June 2013 in our center. A stepwise upgrade diet was given to the children with acute GI-GVHD (Gastrointestinal GVHD) including parenteral and enteral nutrition. A total of 105 patients underwent SCT and seven patients developed grade III-IV acute GI-GVHD. Total parenteral nutrition (TPN) was initiated to all patients after the diagnosis of GI-GVHD and minimal enteral nutrition (1-2 ml/kg/day standard pediatric enteral formula/special meat soup) was given to the patients. GI-GVHD improved in all patients with no change in body weight, and recovery to a normal diet took 10-30 days. Stepwise diet management of oral nutrition contributed to rapid improvement of grades III-IV acute GI-GVHD.
Acute graft-versus-host disease is (GVHD) is a clinicopathologic syndrome involving a severe immune reaction mediated by immunologically competent cells, mainly T lymphocytes resulting in organ dysfunction after stem cell transplantation (SCT) 1 . Gastrointestinal GVHD (GI-GVHD) is one of the most challenging complications after allogeneic SCT with the clinical symptoms of excessive diarrhea, abdominal pain and cramps, nausea, vomiting, gastrointestinal bleeding, dysphagia which can lead to malabsorption, dehydration, severe electrolyte and weight loss. Although there are no standard criteria, the diagnosis of GI-GVHD may be established by means of histological findings such as epithelial cell apoptosis with or without inflammation, epithelial sloughing and the exclusion of infectious causes [2] [3] [4] .
The objectives of diet management in GI-GVHD are to provide adequate nutritional support, control symptoms, heal intestinal lumen with necessary nutrients and satisfy patient preferences when possible 5 . However the patients with GI-GVHD often do not tolerate oral or enteral nutrition. In the acute phase with severe diarrhea (>1 L/day), nil by mouth during days to weeks is required to alleviate gastrointestinal complaints and nutritional support consisting of total parenteral nutrition (TPN). Parenteral nutrition is an integral part of supportive care for these patients but prolonged use of TPN has been associated with multiple complications including infections, fluid and electrolyte imbalances, hyperglycemia, hypertriglyceridemia and hepatic dysfunction. General recommendation is to initiate oral foods when the volume of diarrhea has decreased typically to <500 ml/day; however, certain foods (with low fiber, low fat) may be better tolerated than others [6] [7] [8] .
General guidelines of the Seattle Care Alliance recommend specific upgrade diets for patients with GI-GVHD with limited amounts of fats, fiber, lactose, acidic items and gastrointestinal irritants which are stepwise introduced 9 . Williams and Vickers 10 suggested a "bland diet" for GVHD that was given by stepwise of kinds of nutrients.
In the light of the literature, we performed a stepwise upgrade diet (Table II) including five steps in the children with acute GVHD including parenteral and enteral nutrition, initiating from the first day GI GVHD was diagnosed.
Material and Methods
One hundred and five consecutive patients with a median age of 8.9 years (range 0. 5-16.8) were evaluated retrospectively between April 2010 and June 2013 who underwent SCT at Ankara Children's Hematology and Oncology Hospital Bone Marrow Transplantation Unit. Five patients underwent second transplantation due to relapse of the primary disease or graft rejection. All transplants were from related donors. Totally, 105 patients underwent hematopoitetic stem cell transfusion (HSCT and seven patients developed acute GI-GVHD. Patients with acute GI-GVHD received medical treatment, TPN and a stepwise upgrade diet (Fig. 1) . Patient characteristics are shown in Table I . 
GVHD-
Step I Diet: Minimal enteral nutrition was given as special meat soup or standard pediatric enteral formula (1-2 ml/kg body weight/day). The number of portions of meat soup or formula dose/frequency was increased slowly depending on gut toleration in one or two days.
Step II Diet: One food was tested at a time. Each new food was added to the diet with foods taken previously; after consuming these foods we proceeded to step III diet.
Step I diet was re-initiated in case of persisting diarrhea/cramps. Special meat soup consisting of onion, carrot, potato, wheat flour or Standard pediatric enteral formula Boiled potato Banana GVHD-Step III Diet: The amount of portion of step II foods were increased, and one food at a time was added to other foods which had been already tolerated. After consuming these foods from the list we proceeded to step IV diet. If diarrhea/cramps persisted, step II diet was initiated. Graft-versus-host disease prophylaxis consisted of cyclosporine (CSA) (1-3 mg/kg/day i.v.) and a short course of methotrexate (MTX) (15 mg/ m 2 on day +1 and 10 mg/m 2 on days +3 and +6) in the majority of patients. Acute GVHD was diagnosed on the basis of clinical symptoms and according to evaluation of gut biopsies in all 7 patients 12 . Acute GI-GVHD was graded from 0 (absent) to IV according to previously published criteria according to Glucksberg et al. 13 . Patients with diarrhea 10-19.9 ml/kg/ day were scored as grade I GI-GVHD, patients with diarrhea 20-30 ml/kg/day were scored as grade II GI-GVHD, patients with diarrhea >30 ml/kg/day were scored as grade III GI-GVHD, and patients with severe abdominal pain, with or without ileus were scored as grade IV GI-GVHD. Patients with diarrhea had stool analysis negative for virus, bacteria, fungi, and protozoa. Total PN was initiated to all patients after the diagnosis of GI-GVHD and also minimal enteral nutrition (1-2 ml/kg/day standard pediatric enteral formula/special meat soup) was given to the patients to prevent development of intestinal atrophy 14 . TPN was infused via a CVC overnight, for a minimal duration of 12 hours. TPN administration was stopped when oral dietary intake approached energy and protein requirements. A modified diet protocol including five steps was used (Table II) . This diet is modified from the basis on Williams and Vickers 10 which suggested a "bland diet" for GVHD that was given by stepwise of kinds of nutrients.
Results
In the Bone Marrow Transplantation Unit, 105 patients underwent HSCT seven patients developed acute GI-GVHD (5 of them grade III and 2 of them grade IV). Clinical characteristics of the patients with acute GI-GVHD were presented in Table III the patients for a median period of 14.5 (range 5-30) days. Oral nutrition was initiated from the first day of the protocol except for Case 1 who was unable to eat from the first day. Glutamine was given to all patients with an amount of 0.5 g/kg/day. As expected, period of TPN use was longer in patients with GVHD grade IV when compared to those with GVHD grade III (Grade IV: 21-30 day, Grade III: 10-14 day). The diet management and medical therapy of the patients with acute GI-GVHD were presented in Table IV .
Discussion
The gastrointestinal (GI) tract is one of the major organs affected by GVHD. Injury to the gut during conditioning therapy before SCT plays a pivotal role in the initiation of increasing the translocation of inflammatory stimuli such as endotoxin, which promotes further inflammation and additional GI tract damage. The GI tract is critical to the initiation of the 'cytokine storm' characteristic of acute GVHD 15 . With the development of acute GVHD, patients are often recommended to withhold oral intake (NPO: Nil Per Os, 'bowel rest') to avoid further damage to the GI mucosa. However, this raises a serious concern since NPO care can induce atrophy of the GI mucosa and cause dysfunction of the GI system 5 . Recent preliminary findings suggest that early enteral feeding following SCT is associated with low ratio GVHD and lower infection mortality at 100 days post transplant 16, 17 . In this study; we evaluated the dietary intake patterns of seven children who underwent HSCT and developed GVHD. TPN was initiated to all the patients after the diagnosis of GI-GVHD and simultaneously, minimal enteral trophic nutrition was added to TPN for all patients; thus none of the patients were given a NPO.
Enteral nutrition is generally recommended to maintain digestive and absorptive function as early as possible. Oral intake after HSCT may influence the development of acute GVHD after SCT. Mattsson et al 15 . studied the nutritional history in 231 patients after allogeneic SCT and they found time to-unable-to-oral intake was associated with risk of grades III-IV acute GI-GVHD which was reached at 10%. Otherwise, in our study, rate of grades III-IV acute GI-GVHD was 6%. Oral dietary intake of the patients was evaluated everyday by an experienced dietician, and enteral nutritional support was started as needed. TPN was initiated to all patients after the diagnosis of grades III-IV acute GI-GVHD, and also minimal enteral nutrition was given.
Children who are undergoing bone morrow transplantasyon (BMT), who have GVHD, or who may have inadequate intestinal nutrient absorption postchemotherapy may require TPN. In patients receiving SCT, high dose chemotherapy regimens and total body irradiation can damage the gastrointestinal tract and cause mucositis and enteritis, resulting in difficulty in taking an oral or enteral diet 18 .
In acute phase with severe diarrhea (>1 L/ day), nil by mouth during days to weeks (or even months) is required to alleviate gastrointestinal complaints, and nutritional support consist of TPN. When the volume of diarrhea decreases (typically to <500 ml/day) oral food is restarted, but certain foods (with low fiber and fats) may be better tolerated than others [6] [7] [8] . The common approach in nutritional management of GI-GVHD has been administration of TPN and initiation of oral intake upon recovery of abdominal complaints which may take long time. General guidelines of the Seattle Cancer Care Alliance recommend spesific upgrade diets for patients with GI-GVHD, with limited amounts of fats, fiber, lactose, acidic items and GI irritants which are stepwise introduced. This diet is modified from the basis on Williams and Vickers 10 which suggested a "bland diet" for GVHD that was given by stepwise of kinds of nutrients. The list of nutrients used in the patients presented here was prepared considering the major differences in dietary choices according to cultural differences. Foods that caused diarrhea and crampy abdominal pain were excluded, and steps were diversified and more controlled. It is important to add new foods to patients' diet more slowly than they regularly would.
Imataki et al. 9 investigated effects of this stepwise upgrade diet in 18 patients with GI-GVHD. In that prospective study, the stepwise upgrade diet was compared with a group of historical control patients receiving nil by mouth and TPN alone. Changes in body weight were not significantly different between groups. The oral diet appeared to be safe for the patients suffering from GI-GVHD and recovery to a normal diet tended to be shorter (31 vs. 38 days, p=0.09) in the stepwise upgrade diet group. The patients presented here received minimal enteral nutrition with TPN initiating from the first day of GI-GVHD.
Intestinal GVHD improved in all patients with no change in body weight, and recovery to a normal diet lasted for 10-30 days which were given in the results.
L -glutamine was given to all patients presented here with an amount of 0.3-0.5 g/kg/day. When the patients received TPN, glutamine was added via intravenous dipeptiven ® solution. In experimental and clinical studies, supplementation of glutamine has been demonstrated to restore the integrity of the GI mucosa and decreased bacterial translocation during cancer treatment. The nonessential amino acid glutamine is precursor for nucleotide synthesis; rapidly dividing cells, such as enterocytes, are most likely to suffer from a shortage of glutamine. During stress and trauma endogenous production of glutamine may become insufficient while consumption of glutamine by lymphocytes and enterocytes is increased. Glutamine not only modulates the immune system function in the digestive tract, but may also promote intestinal healing and reduce the severity of mucositis and GVHD. Cochrane review concluded that oral glutamine may reduce mucositis, days of opioids and risk of GVHD 2 .
In conclusion, according to our observation in a small group of patients with grade III-IV GI GVHD, it may be stated that early initiated advanced nutritional support and stepwise diet management provides rapid improvement in digestive tract and may accelerate recovery period in children with grades III-IV acute GI GVHD.
